MenoGeniX's Convertible Note - III Round

MenoGeniX raised a round of funding on December 14, 2017.

MenoGeniX is a clinical stage biotechnology company focused on the development of an approved drug, in a new indication, menopause, and the menopause-like symptoms that occur in certain breast and pro…

Articles about MenoGeniX's Convertible Note - III Round: